Back to Search
JORDAN WHALEY, PHARMD
PHARMD
Pharmacist
NPI: 1952134843Individual
Specialties, Licenses & Credentials
PharmacistPrimary
Pharmacist
Code: 183500000X
48330(TN)
Research & Publications (10)
(-)-Deprenyl inhibits vascular hyperpermeability after hemorrhagic shock.
PMID 19373132·Shock·2010
7-preclinical
17beta-estradiol mediates protection against microvascular endothelial cell hyperpermeability.
PMID 19185107·Am J Surg·2009
7-preclinical
Causes and consequences of zinc dyshomeostasis in rats with chronic aldosteronism.
PMID 18806605·J Cardiovasc Pharmacol·2008
7-preclinical
Aglycone exploration of C-arylglucoside inhibitors of renal sodium-dependent glucose transporter SGLT2.
PMID 18707880·Bioorg Med Chem Lett·2008
4-observational
Dapagliflozin, a selective SGLT2 inhibitor, improves glucose homeostasis in normal and diabetic rats.
PMID 18356408·Diabetes·2008
7-preclinical
Discovery of dapagliflozin: a potent, selective renal sodium-dependent glucose cotransporter 2 (SGLT2) inhibitor for the treatment of type 2 diabetes.
PMID 18260618·J Med Chem·2008
7-preclinical
The dual peroxisome proliferator-activated receptor alpha/gamma activator muraglitazar prevents the natural progression of diabetes in db/db mice.
PMID 17259449·J Pharmacol Exp Ther·2007
7-preclinical
Consensus statement: Atlantic Coast Contaminants Workshop 2000.
PMID 11748039·Environ Health Perspect·2001
7-preclinical
The relationship between serum levels of YKL-40 and disease progression in patients with early rheumatoid arthritis.
PMID 11132209·Scand J Rheumatol·2000
8-other
Data courtesy of the U.S. National Library of Medicine (NLM). Ltrl is not affiliated with or endorsed by NLM.
Contact & Hours
- Address
- 6005 KINGSTON PIKE
KNOXVILLE, TN 37919 - Phone
- (865) 588-5156
Quick Facts
- NPI
- 1952134843
- Entity Type
- Individual
- Gender
- Female
- Medicare
- Not confirmed
- Specialties
- 1
- Locations
- 1
- Publications
- 10
Are you this provider?
Claim Your Profile